Key result
There was no significant difference in the frequencies of chromosomal abnormalities, Factor V Leiden, or Prothrombin G20210A mutations between couples with two versus more than two recurrent pregnancy losses.
Why the study?
Recurrent pregnancy loss definitions vary between two or more versus three or more losses, leaving uncertain whether parental chromosome abnormalities and hereditary thrombophilias differ between these groups.
Is there a difference in the frequency of chromosomal abnormalities, Factor V Leiden, and Prothrombin G20210A mutations between couples with two versus more than two recurrent pregnancy losses?
Observational (n=171)
Yes
Is there a difference in the frequency of chromosomal abnormalities, Factor V Leiden, and Prothrombin G20210A mutations between couples with two versus more than two recurrent pregnancy losses?
Answers are grounded in this paper and cite their sources.
The frequency of chromosomal abnormalities and hereditary thrombophilia mutations does not differ significantly between couples with two versus more than two recurrent pregnancy losses, suggesting a similar testing approach is appropriate for both groups.
Objective: Recurrent pregnancy loss is defined as the loss of two or more pregnancies in some sources, or three or more in others, before 20-24 weeks of gestation. The causes being investigated include parental chromosomal abnormalities and hereditary thrombophilia. We aimed to reveal the frequency of parental chromosome abnormalities, Prothrombin G20210A mutations (PGM), and Factor V Leiden (FVL) in couples presenting with recurrent pregnancy losses and to test whether there is a significant difference between two and more than two pregnancy losses. Materials and Methods: A total of 171 couples who presented to the Medical Genetics outpatient clinics of two tertiary hospitals located in Bolu and Hatay provinces due to a history of recurrent pregnancy loss were evaluated. Demographic data, medical and family history, chromosomal analysis results of the couples, and FVL and PGM results of the women were recorded. Results: We detected chromosomal abnormalities in 2.9% of those evaluated. Factor V Leiden frequency was found to be 11.5% and PGM frequency was 3%. No statistically significant distinction was obtained between the groups, categorized as those with two and more than two pregnancy losses, in terms of the occurrence of chromosomal abnormalities (p=0.65), FVL (p=0.58), and PGM (p=0.65). Conclusion: A similar approach to requesting a test can be taken for both patient groups. Due to the limited number of patients, a meta-analysis of this result with other case series in Turkey would be beneficial.
No takes yet. Share an insight, caveat, or question.
Özkalaycı et al. (2025) conducted an observational in Recurrent pregnancy loss (n=171). Three or more pregnancy losses vs. Two pregnancy losses was evaluated on Factor V Leiden mutation frequency (p=0.58). There was no significant difference in the frequencies of chromosomal abnormalities, Factor V Leiden, or Prothrombin G20210A mutations between couples with two versus more than two recurrent pregnancy losses.
Synapse has enriched 10 related papers. Consider them for comparative context: